Sana Biotechnology, Inc.: cashflow_financing
| Value | {"amount": 631751000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-12-31 |
| Status | current |
| Entity | Sana Biotechnology, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:57:40.760595+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c7638266-3fa8-4e0a-87c2-2bc6700eace7
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-22-010539 · Open the official SEC filing →Retrieved: 2026-08-19T17:57:40.760595+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001770121/cashflow-financing/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c7638266-3fa8-4e0a-87c2-2bc6700eace7
History
- no predecessors — first report